IRIS Accounts Production v24.3.2.46 10391831 director 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103918312023-09-30103918312024-09-30103918312023-10-012024-09-30103918312022-09-30103918312022-10-012023-09-30103918312023-09-3010391831ns15:EnglandWales2023-10-012024-09-3010391831ns14:PoundSterling2023-10-012024-09-3010391831ns10:Director12023-10-012024-09-3010391831ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010391831ns10:SmallEntities2023-10-012024-09-3010391831ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3010391831ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3010391831ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3010391831ns10:FullAccounts2023-10-012024-09-3010391831ns10:OrdinaryShareClass12023-10-012024-09-3010391831ns5:CurrentFinancialInstruments2024-09-3010391831ns5:CurrentFinancialInstruments2023-09-3010391831ns5:ShareCapital2024-09-3010391831ns5:ShareCapital2023-09-3010391831ns5:RetainedEarningsAccumulatedLosses2024-09-3010391831ns5:RetainedEarningsAccumulatedLosses2023-09-3010391831ns10:RegisteredOffice2023-10-012024-09-3010391831ns5:ComputerEquipment2023-09-3010391831ns5:ComputerEquipment2023-10-012024-09-3010391831ns5:ComputerEquipment2024-09-3010391831ns5:ComputerEquipment2023-09-3010391831ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-09-3010391831ns5:AdditionsToInvestmentsns5:UnlistedNon-exchangeTraded2024-09-3010391831ns5:UnlistedNon-exchangeTradedns5:RevaluationsIncreaseDecreaseInInvestments2024-09-3010391831ns5:UnlistedNon-exchangeTradedns5:CostValuation2024-09-3010391831ns5:UnlistedNon-exchangeTraded2024-09-3010391831ns5:UnlistedNon-exchangeTraded2023-09-3010391831ns10:OrdinaryShareClass12024-09-30103918311ns10:Director12023-09-30103918311ns10:Director12022-09-30103918311ns10:Director12023-10-012024-09-30103918311ns10:Director12022-10-012023-09-30103918311ns10:Director12024-09-30103918311ns10:Director12023-09-30
REGISTERED NUMBER: 10391831 (England and Wales)















Unaudited Financial Statements for the Year Ended 30th September 2024

for

W.B. Anaesthetic Services Limited

W.B. Anaesthetic Services Limited (Registered number: 10391831)






Contents of the Financial Statements
for the Year Ended 30th September 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


W.B. Anaesthetic Services Limited (Registered number: 10391831)

Balance Sheet
30th September 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,744 626
Investments 5 400,147 326,672
401,891 327,298

CURRENT ASSETS
Debtors 6 1,884 -
Cash at bank 87,299 83,642
89,183 83,642
CREDITORS
Amounts falling due within one year 7 17,554 19,749
NET CURRENT ASSETS 71,629 63,893
TOTAL ASSETS LESS CURRENT
LIABILITIES

473,520

391,191

PROVISIONS FOR LIABILITIES 331 119
NET ASSETS 473,189 391,072

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 473,089 390,972
SHAREHOLDERS' FUNDS 473,189 391,072

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 17th March 2025 and were signed by:



Dr W E Bickerstaffe - Director


W.B. Anaesthetic Services Limited (Registered number: 10391831)

Notes to the Financial Statements
for the Year Ended 30th September 2024

1. COMPANY INFORMATION

W.B. Anaesthetic Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10391831

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer Equipment - 25% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

W.B. Anaesthetic Services Limited (Registered number: 10391831)

Notes to the Financial Statements - continued
for the Year Ended 30th September 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Fixed asset investments
Fixed Asset Investment is a Prudential Investment Plan measured at market value. At each reporting date the increase/decrease in market value is measured immediately in the profit and loss.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1st October 2023 3,221
Additions 1,582
Disposals (2,281 )
At 30th September 2024 2,522
DEPRECIATION
At 1st October 2023 2,595
Charge for year 464
Eliminated on disposal (2,281 )
At 30th September 2024 778
NET BOOK VALUE
At 30th September 2024 1,744
At 30th September 2023 626

5. FIXED ASSET INVESTMENTS
Fixed
Asset
Investments
£   
COST OR VALUATION
At 1st October 2023 326,672
Additions 50,001
Revaluations 23,474
At 30th September 2024 400,147
NET BOOK VALUE
At 30th September 2024 400,147
At 30th September 2023 326,672

W.B. Anaesthetic Services Limited (Registered number: 10391831)

Notes to the Financial Statements - continued
for the Year Ended 30th September 2024

5. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 30th September 2024 is represented by:

Fixed
Asset
Investments
£   
Valuation in 2023 326,672
Valuation in 2024 73,475
400,147

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 1,884 -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Tax 16,075 18,289
Directors' current accounts 178 134
Accrued expenses 1,301 1,326
17,554 19,749

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
100 Ordinary A 1 100 100

Ordinary A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30th September 2024 and 30th September 2023:

30.9.24 30.9.23
£    £   
Dr W E Bickerstaffe
Balance outstanding at start of year (134 ) (62 )
Amounts advanced 1,268 22,840
Amounts repaid (1,312 ) (22,912 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (178 ) (134 )

This loan is repayable on demand and no interest was charged in the year.

10. CONTROL

The ultimate controlling party is Dr W Bickerstaffe by virtue of his 100% holding of the voting share capital.